内动脉样硬化疾病的最新翻译研究模型
Grace Prochilo1, Alissa Pfeffer1, Stephanie Du1
1Departments of Neurology (G.P., A.P., S.D., D.S.L., J.D.H.), David Geffen School of Medicine, University of California, Los Angeles.
Stroke
|May 13, 2024
概括
内动脉样硬化疾病 (ICAD) 研究需要更好的模型. 本综述评估了当前的模型,以提高对缺血性中风的主要原因的理解和开发新疗法.
科学领域:
- 神经科学是一个神经科学.
- 心血管研究研究心血管研究
- 病理生理学 病理生理学
背景情况:
- 内动脉样硬化疾病 (ICAD) 是全球缺血性中风的主要原因.
- 有限的组织学样本和实验模型阻碍了ICAD病理生理学研究.
- 当前的理解往往从额外动脉样硬化得出推断,这与其显著不同.
研究的目的:
- 审查和评估现有的体内和体外模型来研究ICAD.
- 确定当前实验方法的局限性和优势.
- 引导ICAD研究和治疗策略的改进模型的开发.
主要方法:
- 对ICAD现有的实验模型进行系统的文献审查.
- 对研究动脉样硬化过程的模型适应性的分析.
- 内与外动脉样硬化模型的比较评估.
主要成果:
- 现有的ICAD模型在完全回顾疾病病理生理学方面存在重大局限性.
- 内和外动脉之间的差异需要特定的建模方法.
- 目前的模型不足以开发针对性和有效的ICAD治疗方法.
结论:
- 开发强大的和特定的实验模型对于推进ICAD研究至关重要.
- 改进的模型将有助于更深入地理解ICAD病原学的机制.
- 更好的模型对于推动新的治疗策略来降低ICAD患者中风风险至关重要.
相关概念视频
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...